Alternative Support for Rural and Isolated Women in an HMO

This study has been completed.
Sponsor:
Collaborator:
University of California, Berkeley
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00186212
First received: September 13, 2005
Last updated: June 29, 2011
Last verified: June 2011
  Purpose

Evaluate the effects of a workbook/journal for helping isolated women to cope with breast cancer.


Condition Intervention Phase
Stress Disorders, Post-traumatic
Depression
Breast Cancer
Behavioral: workbook/journal on coping with breast cancer
Behavioral: standard educational materials on breast cancer
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Alternative Support for Rural and Isolated Women in an HMO

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • depression
  • posttraumatic stress disorder

Enrollment: 150
Study Start Date: September 2000
Study Completion Date: May 2002
Primary Completion Date: May 2002 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 1) is a woman; and 2) has been diagnosed with primary breast cancer

Exclusion Criteria:

  • 1) is under 18; or 2) can not speak and read in English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00186212

Locations
United States, California
Stanford University
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
University of California, Berkeley
Investigators
Principal Investigator: Cheryl Koopman, Ph.D. Stanford University
  More Information

No publications provided

Responsible Party: Cheryl Koopman, Ph.D., Professor (Research), Stanford University
ClinicalTrials.gov Identifier: NCT00186212     History of Changes
Other Study ID Numbers: 5BB-1801
Study First Received: September 13, 2005
Last Updated: June 29, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Depression
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Anxiety Disorders
Behavioral Symptoms
Breast Diseases
Mental Disorders
Neoplasms
Neoplasms by Site
Skin Diseases

ClinicalTrials.gov processed this record on October 23, 2014